DROZ DIT BUSSET, MICHELE
DROZ DIT BUSSET, MICHELE
Universita' degli Studi di MILANO
Resection of Retro-Hepatic Vena Cava (RHVC) En-bloc with Caudate Lobe without Vascular Exclusion for a Low Grade Leiomyosarcoma of Inferior Vena Cava
2021 M. Altomare, C. Sposito, E. Regalia, J. Coppa, M. Flores, E. Manzo, M. Droz Dit Busset, V. Mazzaferro
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma.
2019 V. Mazzaferro, B. El-Rayes, M. Droz dit Busset, C. Cotsoglou, W. Harris, N. Damjanov, G. Masi, L. Rimassa, N. Personeni, F. Braiteh, V. Zagonel, K. Papadopoulos, T. Hall, Y. Wang, B. Schwartz, J. Kazakin, S. Bhoori, F. de Braud, W. Shaib
Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection
2019 M. Milione, P. Maisonneuve, A. Pellegrinelli, P. Spaggiari, G. Centonze, J. Coppa, G. Delconte, M. Droz Dit Busset, O. Lanhazo, G. Pruneri, V. Mazzaferro
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula : A Prospective Clinical Study
2019 V. Mazzaferro, M. Virdis, C. Sposito, C. Cotsoglou, M. Droz Dit Busset, M. Bongini, M. Flores, N. Prinzi, J. Coppa
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases
2019 F. Pietrantonio, C. Cotsoglou, G. Fucà, S. Lo Vullo, F. Nichetti, M. Milione, J. Coppa, M. Vaiani, A. Alessi, M. Prisciandaro, M. Droz-Dit Busset, F. Morano, S. Corallo, S. Lazzat, M. Antista, A. Mennitto, G. Randon, A. Raimondi, A. Belfiore, B. Padovano, F. Perrone, L. Mariani, M. Di Bartolomeo, F. de Braud, V. Mazzaferro
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma
2019 C. Raggi, K. Fiaccadori, M. Pastore, M. Correnti, B. Piombanti, E. Forti, N. Navari, G. Abbadessa, T. Hall, A. Destro, L. Di Tommaso, M. Roncalli, F. Meng, S. Glaser, E. Rovida, C. Peraldo-Neia, P. Olaizola, J.M. Banales, A. Gerussi, A. Elvevi, M. Droz Dit Busset, S. Bhoori, V. Mazzaferro, G. Alpini, F. Marra, P. Invernizzi
Alpha-Fetoprotein (AFP) in liver transplantation for HCC: The lower, the better
2018 V. Mazzaferro, M. Droz Dit Busset, S. Bhoori
Proposal of Prognostic Survival Models before and after Liver Resection for Hepatocellular Carcinoma in Potentially Transplantable Patients.
2018 S. Di Sandro, C. Sposito, A. Lauterio, M. Najjar, M. Droz Dit Busset, V. Buscemi, M. Flores Reyes, R. De Carlis, V. Mazzaferro, L. De Carlis
The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors : Pros and cons
2017 C. Sposito, M. Droz Dit Busset, D. Citterio, M. Bongini, V. Mazzaferro
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA)
2016 V.M. Mazzaferro, W. Shaib, L. Rimassa, W. Harris, N. Personeni, B. El-rayes, A. Tolcher, T. Hall, Y. Wang, B. Schwartz, J. Kazakin, M. DROZ DIT BUSSET, C. Cotsoglou, K. Papadopoulos